Haikou, Hainan, September 19, 2024- In the context of globalization, cross-border pharmaceutical cooperation is becoming an important force driving industry development. Qizhouke, as a leading cross-border pharmaceutical enterprise in China, recently welcomed a delegation of entrepreneurs from different industries to jointly explore and examine the potential for cooperation in cross-border pharmaceutical projects.
The inspection activity was personally hosted by Mr. Li from Qizhouke, aiming to showcase the company's latest progress and achievements in the cross-border pharmaceutical field. The delegation members include business leaders from various fields such as medical equipment, pharmaceuticals, biotechnology, health insurance, and international trade.
During this inspection, I gained a detailed understanding of the company's operational methods and a deep understanding of the big health industry. In addition, a special seminar was arranged to have in-depth discussions on the challenges and opportunities faced by current cross-border pharmaceutical cooperation.
After in-depth research and discussion, the delegation members highly praised the professional ability and potential for cooperation of Qizhou Ke. Several entrepreneurs have stated that conducting on-site inspections has not only deepened their understanding of cross-border pharmaceutical projects, but also provided valuable references for their future business decisions.
With the continuous integration of the global pharmaceutical market, Qizhouke will continue to play its leading role in cross-border pharmaceutical cooperation, working together with industry partners to create a new chapter in the cross-border pharmaceutical industry.
